Latest filing published 07 Aug 2026 for Braveheart Bio, Inc., €1.3M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Travis Murdoch: trading record in brief
This profile gathers the share dealings of Travis Murdoch across 2 companies, led by Zymergen Inc. and Braveheart Bio, Inc. Over a trading history stretching from 14 February 2022 to 7 August 2026, the count stands at 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €1.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. 2026 to date brings 1 purchase and no sales.
Most recently, on 7 August 2026, the filings show an open-market purchase worth €1.3M in Braveheart Bio, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Travis Murdoch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 83,333 shares@ US$18.00100.0% of flowCommon StockSEC:0001470831-26-000798:0Canonical exit: 5 Nov 2026 (T+90)
- 79,697 sharesCommon StockSEC:0001645842-22-000142:0
- 50,000 shares0Common StockSEC:0001645842-22-000096:0
- 29,697 shares0Common StockSEC:0001645842-22-000019:0
4 of 4 declarations
